Chemours - CC Stock Forecast, Price & News

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Chemours Price Performance

Shares of NYSE:CC traded down $0.25 during midday trading on Friday, reaching $36.94. 6,739 shares of the stock traded hands, compared to its average volume of 1,199,935. The company has a debt-to-equity ratio of 3.01, a current ratio of 1.91 and a quick ratio of 1.27. The stock has a market capitalization of $5.73 billion, a PE ratio of 6.94, a P/E/G ratio of 0.45 and a beta of 1.82. Chemours has a one year low of $22.56 and a one year high of $44.95. The company's 50 day moving average is $33.55 and its 200 day moving average is $33.88.

Chemours (NYSE:CC - Get Rating) last posted its earnings results on Thursday, July 28th. The specialty chemicals company reported $1.89 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.47. The firm had revenue of $1.92 billion during the quarter, compared to the consensus estimate of $1.84 billion. Chemours had a return on equity of 79.77% and a net margin of 12.72%. The company's quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.20 EPS. On average, equities research analysts anticipate that Chemours will post 5.6 earnings per share for the current year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 15th. Investors of record on Monday, August 15th will be given a $0.25 dividend. The ex-dividend date of this dividend is Friday, August 12th. This represents a $1.00 dividend on an annualized basis and a yield of 2.71%. Chemours's dividend payout ratio is presently 18.66%.

Wall Street Analyst Weigh In

Several analysts have recently commented on CC shares. Royal Bank of Canada raised their price objective on shares of Chemours from $44.00 to $48.00 and gave the company an "outperform" rating in a research report on Monday, August 1st. StockNews.com upgraded shares of Chemours from a "buy" rating to a "strong-buy" rating in a research report on Friday, July 29th. Barclays upped their price target on Chemours from $37.00 to $46.00 in a research note on Monday, May 9th. Bank of America downgraded shares of Chemours from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $48.00 to $44.00 in a report on Tuesday, June 14th. Finally, Citigroup raised their target price on shares of Chemours to $36.00 in a research note on Tuesday, August 9th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $40.17.

Insider Buying and Selling

In related news, insider Edwin C. Sparks sold 22,142 shares of the firm's stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $43.59, for a total value of $965,169.78. Following the completion of the sale, the insider now directly owns 101,038 shares in the company, valued at $4,404,246.42. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 3.04% of the stock is owned by corporate insiders.